The women of Levin Simes lead both within the firm and in the courtroom. A recent study revealed that only 16 percent of multidistrict litigations (MDL) are led by women attorneys – leaving the world of MDLs largely dominated by male attorneys. This disproportionality of male attorneys existed even when the litigation involved harms that were only suffered by women as a result of transvaginal mesh products.
The women attorneys of our firms sought to change that. In 2013, Levin Simes Abrams attorneys were appointed co-lead counsel in the national litigation against American Medical Systems – one of the largest manufacturers of transvaginal mesh slings and prolapse kits. For the past four years, we fought for the thousands of women across the nation harmed by these defective products and sought to bring justice for the permanent complications these women were forced to suffer.
Rachel Abrams is the lead partner of the firm’s mass tort medical device and pharmaceutical litigations with an incredibly extensive list of leadership appointments in several national litigations. Rachel co-chaired the Science and Expert Committee in In re Zyprexa and sat on the Science and Expert Committee for in the In re Depuy ASR Hip Implant litigation. She also sits on the Plaintiffs Steering Committee for multiple litigations including: In re Zyprexa; California State Sulzer hip implant litigation; In re Avandia, DePuy Hip Implant litigation; Mirena, Stryker Hip Implant; Testerone Replacement Therapy, as well as the transvaginal mesh litigation against all manufacturers of mesh sling and prolapse products, including Boston Scientific Corp. and Ethicon/Gynecare (Johnson and Johnson).